Moreover, miRNA-21 can be used as a potential biomarker for early detection of HCC combined with vascular endothelial growth factor (VEGF) and α-Fetoprotein (AFP) [9–11]. The gene discussed is VEGFA; the disease is hepatocellular carcinoma.